{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T11:36:48Z","timestamp":1725536208616},"publisher-location":"Berlin, Heidelberg","reference-count":37,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783540889540"},{"type":"electronic","value":"9783540889557"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-3-540-88955-7_16","type":"book-chapter","created":{"date-parts":[[2009,8,12]],"date-time":"2009-08-12T18:02:39Z","timestamp":1250100159000},"page":"387-396","source":"Crossref","is-referenced-by-count":0,"title":["Schizophrenia"],"prefix":"10.1007","author":[{"given":"F. Markus","family":"Leweke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,24]]},"reference":[{"key":"16_CR1_16","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","volume":"2","author":"S Andreasson","year":"1987","unstructured":"Andreasson S, Allebeck P, Engstrom A et al. (1987) Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 2:1483\u20131486","journal-title":"Lancet"},{"key":"16_CR2_16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1600-0447.1989.tb10296.x","volume":"79","author":"S Andreasson","year":"1989","unstructured":"Andreasson S, Allebeck P, Rydberg U (1989) Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiat Scand 79:505\u2013510","journal-title":"Acta Psychiat Scand"},{"key":"16_CR3_16","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","volume":"325","author":"L Arseneault","year":"2002","unstructured":"Arseneault L, Cannon M, Poulton R et al. (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Br Med J 325:1212\u20131213","journal-title":"Br Med J"},{"key":"16_CR4_16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1192\/bjp.184.2.110","volume":"184","author":"L Arseneault","year":"2004","unstructured":"Arseneault L, Cannon M, Witton J et al. (2004) Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184:110\u2013117","journal-title":"Br J Psychiatry"},{"key":"16_CR5_16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","volume":"103","author":"B Dean","year":"2001","unstructured":"Dean B, Sundram S, Bradbury R et al. (2001) Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 103:9\u201315","journal-title":"Neuroscience"},{"key":"16_CR6_16","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","volume":"29","author":"CD D'Souza","year":"2004","unstructured":"D'Souza CD, Perry E, MacDougall L et al. (2004) The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29:1558\u20131572","journal-title":"Neuropsychopharmacology"},{"key":"16_CR7_16","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","volume":"57","author":"DC D'Souza","year":"2005","unstructured":"D'Souza DC, Abi-Saab WM, Madonick S et al. (2005) Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry 57:594\u2013608","journal-title":"Biol Psychiatry"},{"key":"16_CR8_16","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/archpsyc.65.7.772","volume":"65","author":"SM Eggan","year":"2008","unstructured":"Eggan SM, Hashimoto T, Lewis DA (2008) Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry 65:772\u2013784","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR9_16","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0091-3057(96)00426-1","volume":"56","author":"HM Emrich","year":"1997","unstructured":"Emrich HM, Leweke FM, Schneider U (1997) Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to a dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav 56:803\u2013807","journal-title":"Pharmacol Biochem Behav"},{"key":"16_CR10_16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/7268","volume":"2","author":"A Giuffrida","year":"1999","unstructured":"Giuffrida A, Parsons LH, Kerr TM et al. (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358\u2013363","journal-title":"Nat Neurosci"},{"key":"16_CR11_16","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","volume":"29","author":"A Giuffrida","year":"2004","unstructured":"Giuffrida A, Leweke FM, Gerth CW et al. (2004) Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology 29:2108\u20132114","journal-title":"Neuropsychopharmacology"},{"key":"16_CR12_16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.cpr.2006.09.004","volume":"27","author":"L Gregg","year":"2007","unstructured":"Gregg L, Barrowclough C, Haddock G (2007) Reasons for increased substance use in psychosis. Clin Psychol Rev 27:494\u2013510","journal-title":"Clin Psychol Rev"},{"key":"16_CR13_16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/bmj.38267.664086.63","volume":"330","author":"C Henquet","year":"2005","unstructured":"Henquet C, Krabbendam L, Spauwen J et al. (2005) Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. Br Med J 330:11\u201316","journal-title":"Br Med J"},{"key":"16_CR14_16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.schres.2006.07.023","volume":"88","author":"D Koethe","year":"2006","unstructured":"Koethe D, Gerth CW, Neatby MA et al. (2006) Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness. Schizophr Res 88:142\u2013150","journal-title":"Schizophr Res"},{"key":"16_CR15_16","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00702-007-0660-5","volume":"114","author":"D Koethe","year":"2007","unstructured":"Koethe D, Llenos IC, Dulay JR et al. (2007) Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression. J Neural Transm 114:1055\u20131063","journal-title":"J Neural Transm"},{"key":"16_CR16_16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/schbul\/23.2.195","volume":"23","author":"B Kovasznay","year":"1997","unstructured":"Kovasznay B, Fleischer J, Tanenberg Karant M et al. (1997) Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophr Bull 23:195\u2013201","journal-title":"Schizophr Bull"},{"key":"16_CR17_16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000026487","volume":"37","author":"FM Leweke","year":"1998","unstructured":"Leweke FM, Kampmann C, Radwan M et al. (1998) The effects of tetrahydrocannabinol on the recognition of emotionally charged words: an analysis using event-related brain potentials. Neuropsychobiology 37:104\u2013111","journal-title":"Neuropsychobiology"},{"key":"16_CR18_16","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","volume":"10","author":"FM Leweke","year":"1999","unstructured":"Leweke FM, Giuffrida A, Wurster U et al. (1999a) Elevated endogenous cannabinoids in schizophrenia. Neuroreport 10:1665\u20131669","journal-title":"Neuroreport"},{"key":"16_CR19_16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s002130050884","volume":"142","author":"FM Leweke","year":"1999","unstructured":"Leweke FM, Schneider U, Thies M et al. (1999b) Effects of synthetic \u03949-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man. Psychopharmacology 142:230\u2013235","journal-title":"Psychopharmacology"},{"key":"16_CR20_16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0091-3057(00)00201-X","volume":"66","author":"FM Leweke","year":"2000","unstructured":"Leweke FM, Schneider U, Radwan M et al. (2000) Different effects of nabilone and cannabidiol on binocular depth inversion in man. Pharmacol Biochem Behav 66:175\u2013181","journal-title":"Pharmacol Biochem Behav"},{"key":"16_CR21_16","first-page":"S135","volume":"57","author":"FM Leweke","year":"2005","unstructured":"Leweke FM, Koethe D, Gerth CW et al. (2005) The endocannabinoid modulator cannabidiol as an antipsychotic. Results from the first controlled clinical trial in acute schizophrenia. Biol Psychiat 57:S135","journal-title":"Biol Psychiat"},{"issue":"1\u20133","key":"16_CR22_16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2007.04.025","volume":"94","author":"FM Leweke","year":"2007","unstructured":"Leweke FM, Giuffrida A, Koethe D et al. (2007a) Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. Schizophr Res 94(1\u20133):29\u201336","journal-title":"Schizophr Res"},{"key":"16_CR24_16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","volume":"51","author":"DH Linszen","year":"1994","unstructured":"Linszen DH, Dingemans PM, Lenior ME (1994) Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 51:273\u2013279","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR25_16","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1176\/appi.ajp.161.6.975","volume":"161","author":"HY Meltzer","year":"2004","unstructured":"Meltzer HY, Arvanitis L, Bauer D et al. (2004) Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder. Am J Psychiatry 161:975\u2013984","journal-title":"Am J Psychiatry"},{"key":"16_CR26_16","volume-title":"Du hachisch et de l'ali\u00e9nation mentale, \u00c9tudes psychologiques","author":"Moreau de Tours J-J","year":"1845","unstructured":"Moreau de Tours J-J (1845) Du hachisch et de l'ali\u00e9nation mentale, \u00c9tudes psychologiques. Paris, Fortin et Masson"},{"key":"16_CR27_16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s00221-006-0503-x","volume":"172","author":"KA Newell","year":"2006","unstructured":"Newell KA, Deng C, Huang XF (2006) Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Exp Brain Res 172:556\u2013560","journal-title":"Exp Brain Res"},{"key":"16_CR28_16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s002130050987","volume":"144","author":"M Poncelet","year":"1999","unstructured":"Poncelet M, Barnouin M-C, Breliere J-C et al. (1999) Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils. Psychopharmacology 144:144\u2013150","journal-title":"Psychopharmacology"},{"key":"16_CR29_16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1369-1600.2008.00110.x","volume":"13","author":"M Schneider","year":"2008","unstructured":"Schneider M (2008) Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict Biol 13:253\u2013263","journal-title":"Addict Biol"},{"key":"16_CR30_16","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/sj.npp.1300225","volume":"28","author":"M Schneider","year":"2003","unstructured":"Schneider M, Koch M (2003) Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 28:1760\u20131769","journal-title":"Neuropsychopharmacology"},{"key":"16_CR31_16","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/sj.npp.1300634","volume":"30","author":"M Schneider","year":"2005","unstructured":"Schneider M, Koch M (2005) Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: effects of chronic pubertal cannabinoid treatment. Neuropsychopharmacology 30:944\u2013957","journal-title":"Neuropsychopharmacology"},{"key":"16_CR32_16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00008877-200509000-00018","volume":"16","author":"M Schneider","year":"2005","unstructured":"Schneider M, Drews E, Koch M (2005) Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55, 212-2. Behav Pharmacol 16:447\u2013454","journal-title":"Behav Pharmacol"},{"key":"16_CR33_16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/hup.762","volume":"21","author":"S Sundram","year":"2006","unstructured":"Sundram S (2006) Cannabis and neurodevelopment: implications for psychiatric disorders. Hum Psychopharmacol 21:245\u2013254","journal-title":"Hum Psychopharmacol"},{"key":"16_CR34_16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/aje\/kwf043","volume":"156","author":"J Os van","year":"2002","unstructured":"van Os J, Bak M, Hanssen M et al. (2002) Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 156:319\u2013327","journal-title":"Am J Epidemiol"},{"key":"16_CR35_16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1176\/appi.ajp.161.3.501","volume":"161","author":"ND Veen","year":"2004","unstructured":"Veen ND, Selten JP, van der Tweel I et al. (2004) Cannabis use and age at onset of schizophrenia. Am J Psychiatry 161:501\u2013506","journal-title":"Am J Psychiatry"},{"key":"16_CR36_16","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1136\/bmj.325.7374.1199","volume":"325","author":"S Zammit","year":"2002","unstructured":"Zammit S, Allebeck P, Andreasson S et al. (2002) Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Br Med J 325:1199\u20131203","journal-title":"Br Med J"},{"key":"16_CR37_16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","volume":"28","author":"K Zavitsanou","year":"2004","unstructured":"Zavitsanou K, Garrick T, Huang XF (2004) Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28:355\u2013360","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"16_CR38_16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/BF02244189","volume":"104","author":"AW Zuardi","year":"1991","unstructured":"Zuardi AW, Rodrigues JA, Cunha JM (1991) Effects of cannabidiol in animal models predictive of antipsychotic activity. Psychopharmacology 104:260\u2013264","journal-title":"Psychopharmacology"}],"container-title":["Current Topics in Behavioral Neurosciences","Behavioral Neurobiology of the Endocannabinoid System"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-88955-7_16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T08:13:09Z","timestamp":1619511189000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-88955-7_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783540889540","9783540889557"],"references-count":37,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-88955-7_16","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"type":"print","value":"1866-3370"},{"type":"electronic","value":"1866-3389"}],"subject":[],"published":{"date-parts":[[2009]]}}}